Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor most people, 7.5mg is not a maintenance dose of Mounjaro. It sits in the middle of a six-strength titration schedule, and whether it becomes your long-term dose depends entirely on how your body responds and what your prescriber decides is right for you. That said, some people do settle at 7.5mg for the long term — the licensed schedule does not set a single fixed maintenance level for everyone. Mounjaro (tirzepatide) is a prescription-only medicine, so these decisions are made through clinical assessment, not by the patient alone. You can read the full dosing schedule on the NHS tirzepatide medicines page.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's a natural question. You've been on Mounjaro for roughly three months, you've gone from 2.5mg to 5mg and now to 7.5mg, and the process of stepping up every four weeks is starting to feel significant. Some people feel noticeably different at 7.5mg (appetite more settled, energy shifting) and wonder whether there's any reason to keep going higher.
Here's the honest answer: 7.5mg is a mid-point, not a destination. The licensed schedule runs all the way to 15mg, and the clinical expectation is that titration continues unless your prescriber has a good reason to hold. Those reasons do exist, if side effects at a given dose are persistent rather than short-lived, or if your weight loss is already progressing well and both you and your prescriber are satisfied with how treatment is going, staying at 7.5mg can be a considered clinical decision rather than a pause on the way up.
What it is not is a decision you should make on your own. The concept of a Mounjaro maintenance dose is less about a specific number and more about reaching the point where your prescriber judges that the balance of benefit and tolerability is right for you personally. That could be 7.5mg. It could equally be 10mg, 12.5mg or 15mg. Some people never reach 15mg and do extremely well. The number on the pen is not a measure of commitment.
Tirzepatide's titration schedule is designed specifically to give your body time to adjust to the medicine before each step up. The 2.5mg starting dose is there to settle your system, and each subsequent four-week period at a new strength gives your gut receptors time to adapt before the dose changes again. By the time you reach 7.5mg, you have already had around eight weeks at lower doses.
NICE's appraisal of tirzepatide, TA1026, notes that treatment should be reviewed at six months: if you have not lost at least five percent of your body weight at the highest dose you can tolerate, continuing is reassessed. That six-month point often falls somewhere between 7.5mg and 12.5mg for many patients, which is part of why the question about whether 7.5mg is enough comes up so often.
If you are wondering how 7.5mg compares to what happens at 5mg, the same question about 5mg has its own answer, the logic overlaps but the context differs. And if you want the full picture of how the dose journey tends to unfold over time, understanding tirzepatide's maintenance phase covers it in more detail.
One practical habit worth building now: once a month, when you open your new pen, take thirty seconds to note your current weight alongside the dose. You do not need an app, a note on your phone is fine. It gives you and your prescriber a clear trend to work from at every review, which makes the titration conversation much more grounded.
The most common reason a prescriber might hold at 7.5mg rather than move to 10mg is tolerability. Nausea, loose stools, indigestion and fatigue are the effects people most often notice after a dose increase, and they typically settle within the first week or two. If they haven't settled by the time a review comes around, continuing to titrate upward may not be the right call yet.
This isn't a setback. Staying at a lower dose while your body catches up is clinically sensible, and spending longer at 7.5mg before moving to 10mg does not reduce the medicine's overall effectiveness. The full Mounjaro overview covers the side-effect profile in more detail, including what tends to be short-lived and what warrants a conversation with your prescriber sooner rather than later.
If side effects are genuinely troubling you rather than just mildly inconvenient, reach out to your prescriber rather than reducing the dose yourself. The timing and pace of titration are clinical decisions, and adjusting your own dose carries real risks, including losing the gradual adaptation progress you have already built. At nume, our clinical team offers priority aftercare seven days a week precisely for moments like this.
One practical consideration worth knowing: Mounjaro's UK private cost increases with the dose. Moving from 7.5mg to 10mg or higher means a change in what you pay, which is worth factoring into your thinking about long-term treatment. If cost is part of how you're weighing up your options, the Mounjaro price context page sets out what the UK private market typically looks like and what legitimate pricing includes.
At nume, the price you see covers your free consultation, prescription, tracked next-working-day delivery and seven-day aftercare, no separate fees at each step. Every repeat order is clinically reviewed before it is dispensed, which means your prescriber is actively assessing your progress at each dose rather than just processing a renewal. If you're approaching a titration decision and want a clinical conversation before committing, checking your eligibility is where that starts.
For those already on treatment who are thinking about what comes after a maintenance phase, life after Mounjaro covers what the evidence currently says about stopping, continuing and managing weight long term.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.